Chapter 24 Monitoring Macroautophagy by Major Histocompatibility Complex Class II Presentation of Targeted Antigens

Methods in Enzymology

Volumn 451, Issue C, 2009, Pages 403-421

  Gannagé, Monique ^a   Münz, Christian ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; HLA ANTIGEN CLASS 2; LIGHT CHAIN 3, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; RECOMBINANT PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; AUTOPHAGY; CELL LINE; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; ADAPTIVE IMMUNITY; ANTIGEN DETECTION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ASSAY; ELECTRON MICROSCOPY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LYSOSOME; MAJOR HISTOCOMPATIBILITY COMPLEX; PHAGOSOME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; T LYMPHOCYTE;

AUTOPHAGY; CELL LINE; CELL LINE, TUMOR; GREEN FLUORESCENT PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; RECOMBINANT PROTEINS;

EID: 59249106101     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(08)03624-0     Document Type: Review

References (35)

1. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., von Boehmer H., Bronson R., Dierich A., Benoist C., and Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science 298 (2002) 1395-1401
2. Aniento F., Roche E., Cuervo A.M., and Knecht E. Uptake and degradation of glyceraldehyde-3-phosphate dehydrogenase by rat liver lysosomes. J. Biol. Chem. 268 (1993) 10463-10470
3. + T-cell response. Nat. Rev. Immunol. 4 (2004) 595-602
4. Brazil M.I., Weiss S., and Stockinger B. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules. Eur. J. Immunol. 27 (1997) 1506-1514
5. Bryant P., and Ploegh H. Class II MHC peptide loading by the professionals. Curr. Opin. Immunol. 16 (2004) 96-102
6. Chapman H.A. Endosomal proteases in antigen presentation. Curr. Opin. Immunol. 18 (2006) 78-84
7. Chicz R.M., Urban R.G., Gorga J.C., Vignali D.A., Lane W.S., and Strominger J.L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178 (1993) 27-47
8. Crotzer V.L., Christian R.E., Brooks J.M., Shabanowitz J., Settlage R.E., Marto J.A., White F.M., Rickinson A.B., Hunt D.F., and Engelhard V.H. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines. J. Immunol. 164 (2000) 6120-6129
9. Dengjel J., Schoor O., Fischer R., Reich M., Kraus M., Müller M., Kreymborg K., Altenberend F., Brandenburg J., Kalbacher H., Brock R., Driessen C., et al. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc. Natl. Acad. Sci. USA 102 (2005) 7922-7927
10. Doherty P.C., and Zinkernagel R.M. H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J. Exp. Med. 141 (1975) 502-507
11. Dongre A.R., Kovats S., deRoos P., McCormack A.L., Nakagawa T., Paharkova-Vatchkova V., Eng J., Caldwell H., Yates III J.R., and Rudensky A.Y. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses. Eur. J. Immunol. 31 (2001) 1485-1494
12. Dorfel D., Appel S., Grunebach F., Weck M.M., Müller M.R., Heine A., and Brossart P. Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro transcribed MUC1 RNA. Blood 105 (2005) 3199-3205
13. Fengsrud M., Raiborg C., Berg T.O., Stromhaug P.E., Ueno T., Erichsen E.S., and Seglen P.O. Autophagosome-associated variant isoforms of cytosolic enzymes. Biochem. J. 352 Pt 3 (2000) 773-781
14. + T-cell clones using peptide pulsed mature dendritic cells. J. Immunol. Methods 258 (2001) 111-126
15. Gotch F., Rothbard J., Howland K., Townsend A., and McMichael A. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 326 (1987) 881-882
16. Heessen S., Masucci M.G., and Dantuma N.P. The UBA2 domain functions as an intrinsic stabilization signal that protects Rad23 from proteasomal degradation. Mol. Cell 18 (2005) 225-235
17. + T cells: Ready for direct attack. J. Exp. Med. 203 (2006) 805-808
18. Hoyt M.A., Zich J., Takeuchi J., Zhang M., Govaerts C., and Coffino P. Glycine-alanine repeats impair proper substrate unfolding by the proteasome. EMBO J. 25 (2006) 1720-1729
19. Lee J.W., Epardaud M., Sun J., Becker J.E., Cheng A.C., Yonekura A.R., Heath J.K., and Turley S.J. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat. Immunol. 8 (2007) 181-190
20. Lee S.P., Brooks J.M., Al-Jarrah H., Thomas W.A., Haigh T.A., Taylor G.S., Humme S., Schepers A., Hammerschmidt W., Yates J.L., Rickinson A.B., and Blake N.W. CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1. J. Exp. Med. 199 (2004) 1409-1420
21. Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald-Mullen P.M., Klein G., Kurilla M.G., and Masucci M.G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375 (1995) 685-688
22. Levitskaya J., Sharipo A., Leonchiks A., Ciechanover A., and Masucci M.G. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. USA 94 (1997) 12616-12621
23. Miller G., Robinson J., Heston L., and Lipman M. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection and interference. IARC Sci. Publ. 11 (1975) 395-408
24. Mizushima N., and Klionsky D.J. Protein turnover via autophagy: Implications for metabolism. Annu. Rev. Nutr. 27 (2007) 19-40
25. Mizushima N., Levine B., Cuervo A.M., and Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 451 (2008) 1069-1075
26. Nimmerjahn F., Milosevic S., Behrends U., Jaffee E.M., Pardoll D.M., Bornkamm G.W., and Mautner J. Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy. Eur. J. Immunol. 33 (2003) 1250-1259
27. Ohsumi Y. Molecular dissection of autophagy: Two ubiquitin-like systems. Nat. Rev. Mol. Cell Biol. 2 (2001) 211-216
28. Paludan C., Schmid D., Landthaler M., Vockerodt M., Kube D., Tuschl T., and Münz C. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307 (2005) 593-596
29. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., and Stevanovic S. SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 50 (1999) 213-219
30. Rocha N., and Neefjes J. MHC class II molecules on the move for successful antigen presentation. EMBO J. 27 (2008) 1-5
31. Schmid D., and Münz C. Innate and adaptive immunity through autophagy. Immunity 26 (2007) 11-21
32. Schmid D., Pypaert M., and Münz C. MHC class II antigen loading compartments continuously receive input from autophagosomes. Immunity 26 (2007) 79-92
33. Steinman R.M., and Banchereau J. Taking dendritic cells into medicine. Nature 449 (2007) 419-426
34. Suri A., Walters J.J., Rohrs H.W., Gross M.L., and Unanue E.R. First signature of islet β-cell-derived naturally processed peptides selected by diabetogenic class II MHC molecules. J. Immunol. 180 (2008) 3849-3856
35. Zhou D., Li P., Lott J.M., Hislop A., Canaday D.H., Brutkiewicz R.R., and Blum J.S. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 22 (2005) 571-581